You are here

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Phoenix, Arizona, 85013 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Partial Seizure Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Must have met the inclusion criteria for preceding double-blind study

- Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Cannot have absence seizures

NCT00141336
Pfizer
Completed
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Epilepsy, Partial Seizure Disorder, Partial Epilepsies, Complex Partial Seizure Disorder
NCT00537940
All Genders
18+
Years
Multiple Sites
Partial Seizure Disorder
NCT00141388
All Genders
18+
Years
Multiple Sites
Partial Seizure Disorder
NCT00141336
All Genders
12+
Years
Multiple Sites
Partial Seizure Disorder
NCT00150293
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now